Victor H Leyva-Grado, Rong Hai, Fiona Fernandes, Alan Belicha-Villanueva, Carol Carter, Mark A Yondola
文献索引:J. Mol. Biol. 426(6) , 1308-21, (2014)
全文:HTML全文
We previously demonstrated that ectodomain residue Asp286 in N2 neuraminidase (NA; Asp268 in N1 NA) present in budding-capable NA proteins contributes to productive NA plasma membrane transport partly by mediating escape from tetherin restriction [Yondola MA, Fernandes F, Belicha-Villanueva A, Uccelini M, Gao Q, Carter C, et al. (2011). Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J Virol, 85, 2480-2491]. Budding-incapable NA proteins contain a G at this position and either co-expression of human immunodeficiency virus type 1 vpu or siRNA-mediated depletion of tetherin rescued budding capabilities in these proteins [Yondola MA, Fernandes F, Belicha-Villanueva A, Uccelini M, Gao Q, Carter C, et al. (2011). Budding capability of the influenza virus neuraminidase can be modulated by tetherin. J Virol, 85, 2480-2491]. Furthermore, replacement of D286 with G in budding-capable NA proteins caused loss of function, preventing release of NA virus-like particles (VLPs). Here, we show that mutation of this residue specifically modulates the ability of NA to escape tetherin restriction at the plasma membrane and results in virus attenuation in vivo. Based on immunogold electron microscopy and co-immunoprecipitation assays, both NAD286-containing and NAD286G-containing proteins associated with tetherin in the endoplasmic reticulum (ER). However, the NAD286G loss-of-function mutant also associated with the host factor outside the ER and in plasma-membrane-localized VLPs as visualized using immunogold electron microscopy. We conclude that the presence of aspartate at residue 286 liberates NA from tetherin-dependent restriction upon exit from the ER compartment thus preventing restriction at the plasma membrane. Underscoring the importance of these observations, knockdown of tetherin resulted in a 1-1.5 log increase in influenza virus growth. Additionally, the loss-of-function mutation conferred attenuation in a mouse model of influenza infection as evidenced by a 5-fold increase in LD50 and increases in either percent survival or time to death dependent on the administered dose in vivo. Copyright © 2014 Elsevier Ltd. All rights reserved.
结构式 | 名称/CAS号 | 分子式 | 全部文献 |
---|---|---|---|
![]() |
神经氨酸酶 来源于产气荚膜梭菌
CAS:9001-67-6 |
C9H14N4O3 |
Neuraminidase inhibitors for influenza: a review and public ...
2013-01-01 [Influenza Other Respi. Viruses 7 Suppl 1 , 14-24, (2013)] |
Genetic ancestor of external antigens of pandemic influenza ...
2012-12-01 [Interdiscip. Sci. 4(4) , 282-90, (2012)] |
Nucleic acid-based detection of influenza A virus subtypes H...
2014-01-01 [Euro Surveill. 19(10) , (2014)] |
Department of Health's misguided alert recommending neuramin...
2014-01-01 [BMJ 348 , g1594, (2014)] |
A community cluster of influenza A(H1N1)pdm09 virus exhibiti...
2014-01-01 [Euro Surveill. 19(1) , (2014)] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved